Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
709K
-
Shares change
-
+72.8K
-
Total reported value, excl. options
-
$3.82M
-
Value change
-
+$497K
-
Number of buys
-
9
-
Number of sells
-
-2
-
Price
-
$5.38
Significant Holders of CytoDyn Inc. - COM (CYDY) as of Q4 2020
23 filings reported holding CYDY - CytoDyn Inc. - COM as of Q4 2020.
CytoDyn Inc. - COM (CYDY) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 709K shares
.
Largest 10 shareholders include Firsthand Capital Management, Inc. (323K shares), HOLLENCREST CAPITAL MANAGEMENT (55.8K shares), FAIRFIELD, BUSH & CO. (52.8K shares), L & S Advisors Inc (50.6K shares), Diversified Trust Co (40.8K shares), Next Capital Management LLC (30K shares), Moloney Securities Asset Management, LLC (29.2K shares), S.A. Mason LLC (19K shares), Willis Investment Counsel (17K shares), and Livingston Group Asset Management CO (operating as Southport Capital Management) (17K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.